Over the past 12 months, 0 insiders at GENOCEA BIOSCIENCES, INC. filed 0 open-market SEC Form 4 transactions on GNCA: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 2, 22 | William D ClarkPresident and CEO | SELL | 4.0K | $0.06 | $241 |
| Jun 2, 22 | Diantha DuvallCHIEF FINANCIAL OFFICER | SELL | 1.4K | $0.06 | $81 |
| Jun 2, 22 | Jessica Baker FlechtnerChief Scientific Officer | SELL | 1.6K | $0.06 | $95 |
| Jun 1, 22 | Jacquelyn L SumerCHIEF LEGAL & COMPLIANCE OFF | SELL | 2.5K | $0.06 | $150 |
| May 31, 22 | William D ClarkPresident and CEO | SELL | 117.2K | $0.06 | $7K |
| May 27, 22 | George SiberDirector | SELL | 20.4K | $0.07 | $1K |
| May 26, 22 | Diantha DuvallCHIEF FINANCIAL OFFICER | SELL | 24.4K | $0.08 | $2K |
| May 25, 22 | Jessica Baker FlechtnerChief Scientific Officer | SELL | 16.5K | $0.09 | $1K |
| May 25, 22 | Raymond D Stapleton JrCHIEF TECHNOLOGY OFFICER | SELL | 2.5K | $0.09 | $225 |
| May 25, 22 | Forest BaskettTenPercentOwner | SELL | 4.45M | $0.08 | $356K |
| May 25, 22 | Ali BehbahaniDirector,TenPercentOwner | SELL | 4.45M | $0.08 | $356K |
| May 25, 22 | Carmen ChangTenPercentOwner | SELL | 4.45M | $0.08 | $356K |
| May 25, 22 | Anthony A. Florence Jr.TenPercentOwner | SELL | 4.45M | $0.08 | $356K |
| May 25, 22 | Mohamad MakhzoumiTenPercentOwner | SELL | 4.45M | $0.08 | $356K |
| May 25, 22 | New Enterprise Associates 16, L.p.TenPercentOwner | SELL | 4.45M | $0.08 | $356K |
| May 25, 22 | Scott D SandellTenPercentOwner | SELL | 4.45M | $0.08 | $356K |
| May 25, 22 | Peter W. SonsiniTenPercentOwner | SELL | 4.45M | $0.08 | $356K |
| May 25, 22 | Paul Edward WalkerTenPercentOwner | SELL | 4.45M | $0.08 | $356K |
| May 24, 22 | Forest BaskettTenPercentOwner | SELL | 5.93M | $0.07 | $415K |
| May 24, 22 | Ali BehbahaniDirector,TenPercentOwner | SELL | 5.93M | $0.07 | $415K |
| May 24, 22 | Carmen ChangTenPercentOwner | SELL | 5.93M | $0.07 | $415K |
| May 24, 22 | Anthony A. Florence Jr.TenPercentOwner | SELL | 5.93M | $0.07 | $415K |
| May 24, 22 | Mohamad MakhzoumiTenPercentOwner | SELL | 5.93M | $0.07 | $415K |
| May 24, 22 | New Enterprise Associates 16, L.p.TenPercentOwner | SELL | 5.93M | $0.07 | $415K |
| May 24, 22 | Scott D SandellTenPercentOwner | SELL | 5.93M | $0.07 | $415K |
| May 24, 22 | Peter W. SonsiniTenPercentOwner | SELL | 5.93M | $0.07 | $415K |
| May 24, 22 | Paul Edward WalkerTenPercentOwner | SELL | 5.93M | $0.07 | $415K |
| Apr 4, 22 | Girish N AakaluCHIEF BUSINESS OFFICER | SELL | 963 | $1.25 | $1K |
| Apr 4, 22 | William D ClarkPresident and CEO | SELL | 3.9K | $1.25 | $5K |
| Apr 4, 22 | Thomas Andrew DavisCHIEF MEDICAL OFFICER | SELL | 1.1K | $1.25 | $1K |
| Apr 4, 22 | Diantha DuvallCHIEF FINANCIAL OFFICER | SELL | 963 | $1.25 | $1K |
| Apr 4, 22 | Jessica Baker FlechtnerChief Scientific Officer | SELL | 1.2K | $1.25 | $2K |
| Mar 16, 22 | Girish N AakaluCHIEF BUSINESS OFFICER | SELL | 2.4K | $1.10 | $3K |
| Mar 16, 22 | William D ClarkPresident and CEO | SELL | 11.4K | $1.10 | $13K |
| Mar 16, 22 | Thomas Andrew DavisCHIEF MEDICAL OFFICER | SELL | 2.7K | $1.10 | $3K |
| Mar 16, 22 | Diantha DuvallCHIEF FINANCIAL OFFICER | SELL | 2.9K | $1.10 | $3K |
| Mar 16, 22 | Jessica Baker FlechtnerChief Scientific Officer | SELL | 3.3K | $1.10 | $4K |
Over the past 12 months, insiders at GENOCEA BIOSCIENCES, INC. filed 0 open-market purchases worth $0 and 0 sales worth $0 on GNCA, which makes them mixed over the period. The most recent Form 4 was filed on .
0 different insiders at GENOCEA BIOSCIENCES, INC. filed open-market SEC Form 4 transactions on GNCA over the last 12 months.
InsiderTape plots every GNCA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every GENOCEA BIOSCIENCES, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →